- Home
- RPRX vs GEN Comparison
RPRX vs GEN Comparison
Compare RPRX & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | GEN |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 16.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | GEN |
|---|---|---|
| Price | $39.70 | $27.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $46.00 | $35.43 |
| AVG Volume (30 Days) | 4.3M | ★ 5.3M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.21% | 1.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | 0.91 |
| Revenue | $2,349,844,000.00 | ★ $4,473,000,000.00 |
| Revenue This Year | $37.13 | $26.99 |
| Revenue Next Year | $1.48 | $4.88 |
| P/E Ratio | ★ $22.68 | $29.77 |
| Revenue Growth | 3.70 | ★ 16.15 |
| 52 Week Low | $24.05 | $22.74 |
| 52 Week High | $41.24 | $32.22 |
Technical Indicators
Market Signals| Indicator | RPRX | GEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 56.22 |
| Support Level | $39.24 | $25.97 |
| Resistance Level | $40.50 | $26.82 |
| Average True Range (ATR) | 0.91 | 0.57 |
| MACD | -0.08 | 0.14 |
| Stochastic Oscillator | 76.02 | 84.73 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.